BriaCell Therapeutics Corp (BCTX)
0.5996
-0.05
(-7.75%)
USD |
NASDAQ |
Nov 13, 16:00
0.601
0.00 (0.00%)
After-Hours: 20:00
BriaCell Therapeutics Max Drawdown (5Y): 97.64% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 97.64% |
| September 30, 2024 | 97.64% |
| August 31, 2024 | 97.23% |
| July 31, 2024 | 96.54% |
| June 30, 2024 | 95.67% |
| May 31, 2024 | 95.67% |
| April 30, 2024 | 95.67% |
| March 31, 2024 | 95.67% |
| February 29, 2024 | 95.67% |
| January 31, 2024 | 95.67% |
| December 31, 2023 | 95.67% |
| November 30, 2023 | 95.67% |
| October 31, 2023 | 95.67% |
| September 30, 2023 | 95.67% |
| August 31, 2023 | 95.67% |
| July 31, 2023 | 95.67% |
| June 30, 2023 | 95.67% |
| May 31, 2023 | 95.67% |
| April 30, 2023 | 95.67% |
| March 31, 2023 | 95.67% |
| February 28, 2023 | 95.67% |
| January 31, 2023 | 95.67% |
| December 31, 2022 | 95.67% |
| November 30, 2022 | 95.67% |
| October 31, 2022 | 95.67% |
| Date | Value |
|---|---|
| September 30, 2022 | 95.67% |
| August 31, 2022 | 95.67% |
| July 31, 2022 | 95.67% |
| June 30, 2022 | 95.67% |
| May 31, 2022 | 95.67% |
| April 30, 2022 | 95.67% |
| March 31, 2022 | 95.67% |
| February 28, 2022 | 95.67% |
| January 31, 2022 | 95.67% |
| December 31, 2021 | 95.67% |
| November 30, 2021 | 95.67% |
| October 31, 2021 | 95.67% |
| September 30, 2021 | 95.67% |
| August 31, 2021 | 95.67% |
| July 31, 2021 | 95.67% |
| June 30, 2021 | 95.67% |
| May 31, 2021 | 95.67% |
| April 30, 2021 | 95.67% |
| March 31, 2021 | 95.67% |
| February 28, 2021 | 95.67% |
| January 31, 2021 | 95.67% |
| December 31, 2020 | 95.67% |
| November 30, 2020 | 95.67% |
| October 31, 2020 | 95.67% |
| September 30, 2020 | 94.59% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
94.59%
Minimum
Nov 2019
97.64%
Maximum
Sep 2024
95.58%
Average
95.67%
Median
Oct 2020
Max Drawdown (5Y) Benchmarks
| CeCors Inc | 98.60% |
| Venus Concept Inc | 99.86% |
| Aurinia Pharmaceuticals Inc | 87.58% |
| Edesa Biotech Inc | 99.58% |
| Lexaria Bioscience Corp | 98.90% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -62.78 |
| Beta (5Y) | 1.389 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 94.07% |
| Historical Sharpe Ratio (5Y) | -0.4768 |
| Historical Sortino (5Y) | -0.9829 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 37.33% |